Entyvio and Colitis ulcerative aggravated - a phase IV clinical study of FDA data
Summary:
Colitis ulcerative aggravated is reported as a side effect among people who take Entyvio (vedolizumab), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Humira, and have Colitis.
The phase IV clinical study analyzes which people have Colitis ulcerative aggravated when taking Entyvio. It is created by eHealthMe based on reports of 23,685 people who have side effects when taking Entyvio from the FDA, and is updated regularly.
What is Entyvio?
Entyvio has active ingredients of vedolizumab. It is often used in crohn's disease. eHealthMe is studying from 23,827 Entyvio users. Check the latest studies of Entyvio.
What is Colitis ulcerative aggravated?
Colitis ulcerative aggravated (inflammation of colon with ulcer) is found to be associated with 1,071 drugs and 326 conditions by eHealthMe. Check the latest studies of Colitis ulcerative aggravated.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
23,685 people reported to have side effects when taking Entyvio.
Among them, 2,464 people (10.4%) have Colitis ulcerative aggravated.
Among these 2,464 people:
How long have people been on Entyvio when they have Colitis ulcerative aggravated? *
What is the gender of people who have Colitis ulcerative aggravated when taking Entyvio? *
What is the age of people who have Colitis ulcerative aggravated when taking Entyvio? *
What are other drugs people take besides Entyvio? *
What are other side effects people have besides Colitis ulcerative aggravated? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Entyvio and have Colitis ulcerative aggravated?
- Check whether Colitis ulcerative aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Entyvio:
- Entyvio (23,827 reports)
Colitis ulcerative aggravated treatments and more:
- Colitis ulcerative aggravated (168 reports)
How severe was Colitis ulcerative aggravated and when was it recovered:
Expand to all the drugs that have ingredients of vedolizumab:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Entyvio:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Colitis ulcerative aggravated:
- Colitis ulcerative aggravated (1,071 drugs)
Browse all the conditions that are associated with Colitis ulcerative aggravated:
- Colitis ulcerative aggravated (326 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on vedolizumab (the active ingredients of Entyvio) and Entyvio (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Capillary Leak Syndrome and drugs of ingredients of metformin hydrochloride - a second ago
- Mania and drugs of ingredients of mesalamine - a second ago
- Haemorrhagic Stroke and drugs of ingredients of ergocalciferol - a second ago
- Product Solubility Abnormal and drugs of ingredients of losartan potassium - 3 seconds ago
- Drug interactions of Prednisone and Demadex - 4 seconds ago
- High Blood Pressure and Dental Caries - 4 seconds ago
- Angioneurotic Oedema Aggravated and drugs of ingredients of valsartan - 4 seconds ago
- Nephritis - Interstitial and drugs of ingredients of vortioxetine hydrobromide - 6 seconds ago
- Interstitial Nephritis and drugs of ingredients of vortioxetine hydrobromide - 6 seconds ago
- Rickets and drugs of ingredients of benazepril hydrochloride - 13 seconds ago